236 related articles for article (PubMed ID: 34975910)
1. Current State of Carbohydrate Recognition and C-Type Lectin Receptors in
Kottom TJ; Carmona EM; Limper AH
Front Immunol; 2021; 12():798214. PubMed ID: 34975910
[No Abstract] [Full Text] [Related]
2. Pneumocystis carinii Major Surface Glycoprotein Dampens Macrophage Inflammatory Responses to Fungal β-Glucan.
Kottom TJ; Hebrink DM; Carmona EM; Limper AH
J Infect Dis; 2020 Sep; 222(7):1213-1221. PubMed ID: 32363390
[TBL] [Abstract][Full Text] [Related]
3. Dectin-2 Is a C-Type Lectin Receptor that Recognizes Pneumocystis and Participates in Innate Immune Responses.
Kottom TJ; Hebrink DM; Jenson PE; Marsolek PL; Wüthrich M; Wang H; Klein B; Yamasaki S; Limper AH
Am J Respir Cell Mol Biol; 2018 Feb; 58(2):232-240. PubMed ID: 28886250
[TBL] [Abstract][Full Text] [Related]
4. Additional C-type lectin receptors mediate interactions with
Kottom TJ; Carmona EM; Schaefbauer K; Limper AH
J Med Microbiol; 2021 Dec; 70(12):. PubMed ID: 34889727
[No Abstract] [Full Text] [Related]
5. Myeloid C-type lectin receptors that recognize fungal mannans interact with
Kottom TJ; Hebrink DM; Monteiro JT; Lepenies B; Carmona EM; Wuethrich M; Santo Dias LD; Limper AH
J Med Microbiol; 2019 Nov; 68(11):1649-1654. PubMed ID: 31609198
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of Surface Antigenic Variation in the Human Pathogenic Fungus
Schmid-Siegert E; Richard S; Luraschi A; Mühlethaler K; Pagni M; Hauser PM
mBio; 2017 Nov; 8(6):. PubMed ID: 29114024
[TBL] [Abstract][Full Text] [Related]
7. Antibody response to Pneumocystis jirovecii major surface glycoprotein.
Daly KR; Huang L; Morris A; Koch J; Crothers K; Levin L; Eiser S; Satwah S; Zucchi P; Walzer PD
Emerg Infect Dis; 2006 Aug; 12(8):1231-7. PubMed ID: 16965702
[TBL] [Abstract][Full Text] [Related]
8. CLEC4A and CLEC12B C-type lectin receptors mediate interactions with
Kottom TJ; Carmona EM; Schaefbauer K; Limper AH
J Med Microbiol; 2023 Jun; 72(6):. PubMed ID: 37294293
[No Abstract] [Full Text] [Related]
9. The Interaction of
Kottom TJ; Hebrink DM; Jenson PE; Nandakumar V; Wüthrich M; Wang H; Klein B; Yamasaki S; Lepenies B; Limper AH
J Immunol; 2017 May; 198(9):3515-3525. PubMed ID: 28298521
[No Abstract] [Full Text] [Related]
10. A critical role for CARD9 in pneumocystis pneumonia host defence.
Kottom TJ; Nandakumar V; Hebrink DM; Carmona EM; Limper AH
Cell Microbiol; 2020 Oct; 22(10):e13235. PubMed ID: 32548948
[TBL] [Abstract][Full Text] [Related]
11. Pneumocystis jirovecii infection: Cell wall (1→3)-β-D-glucan biology and diagnostic utility.
Finkelman MA
Crit Rev Microbiol; 2010 Nov; 36(4):271-81. PubMed ID: 20854193
[TBL] [Abstract][Full Text] [Related]
12. Long-term serologic responses to the Pneumocystis jirovecii major surface glycoprotein in HIV-positive individuals with and without P. jirovecii infection.
Walzer PD; Djawe K; Levin L; Daly KR; Koch J; Kingsley L; Witt M; Golub ET; Bream JH; Taiwo B; Morris A
J Infect Dis; 2009 May; 199(9):1335-44. PubMed ID: 19301979
[TBL] [Abstract][Full Text] [Related]
13. Expression Pattern of the Pneumocystis jirovecii Major Surface Glycoprotein Superfamily in Patients with Pneumonia.
Schmid-Siegert E; Richard S; Luraschi A; Mühlethaler K; Pagni M; Hauser PM
J Infect Dis; 2021 Feb; 223(2):310-318. PubMed ID: 32561915
[TBL] [Abstract][Full Text] [Related]
14. Pneumocystis cell wall beta-glucans induce dendritic cell costimulatory molecule expression and inflammatory activation through a Fas-Fas ligand mechanism.
Carmona EM; Vassallo R; Vuk-Pavlovic Z; Standing JE; Kottom TJ; Limper AH
J Immunol; 2006 Jul; 177(1):459-67. PubMed ID: 16785543
[TBL] [Abstract][Full Text] [Related]
15. Conserved natural IgM antibodies mediate innate and adaptive immunity against the opportunistic fungus Pneumocystis murina.
Rapaka RR; Ricks DM; Alcorn JF; Chen K; Khader SA; Zheng M; Plevy S; Bengtén E; Kolls JK
J Exp Med; 2010 Dec; 207(13):2907-19. PubMed ID: 21149550
[TBL] [Abstract][Full Text] [Related]
16. Pneumocystis cell wall beta-glucans stimulate alveolar epithelial cell chemokine generation through nuclear factor-kappaB-dependent mechanisms.
Evans SE; Hahn PY; McCann F; Kottom TJ; Pavlovic' ZV; Limper AH
Am J Respir Cell Mol Biol; 2005 Jun; 32(6):490-7. PubMed ID: 15746433
[TBL] [Abstract][Full Text] [Related]
17. Targeting CARD9 with Small-Molecule Therapeutics Inhibits Innate Immune Signaling and Inflammatory Response to Pneumocystis carinii β-Glucans.
Kottom TJ; Carmona EM; Limper AH
Antimicrob Agents Chemother; 2020 Oct; 64(11):. PubMed ID: 32839216
[No Abstract] [Full Text] [Related]
18. Effects of clinical and environmental factors on bronchoalveolar antibody responses to Pneumocystis jirovecii: A prospective cohort study of HIV+ patients.
Blount RJ; Daly KR; Fong S; Chang E; Grieco K; Greene M; Stone S; Balmes J; Miller RF; Walzer PD; Huang L
PLoS One; 2017; 12(7):e0180212. PubMed ID: 28692651
[TBL] [Abstract][Full Text] [Related]
19. Discordant antibody and cellular responses to Pneumocystis major surface glycoprotein variants in mice.
Bishop LR; Helman D; Kovacs JA
BMC Immunol; 2012 Jul; 13():39. PubMed ID: 22788748
[TBL] [Abstract][Full Text] [Related]
20. Serologic responses to recombinant Pneumocystis jirovecii major surface glycoprotein among Ugandan patients with respiratory symptoms.
Blount RJ; Jarlsberg LG; Daly KR; Worodria W; Davis JL; Cattamanchi A; Djawe K; Andama A; Koch J; Walzer PD; Huang L;
PLoS One; 2012; 7(12):e51545. PubMed ID: 23284710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
